HomeENTA • NASDAQ
add
Enanta Pharmaceuticals Inc
Previous close
$11.35
Day range
$11.00 - $11.31
Year range
$8.08 - $17.80
Market cap
234.56M USD
Avg Volume
156.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 17.97M | -4.88% |
Operating expense | 42.16M | -24.19% |
Net income | -22.66M | 42.00% |
Net profit margin | -126.08 | 39.03% |
Earnings per share | -1.07 | 42.47% |
EBITDA | -23.59M | 34.58% |
Effective tax rate | 1.71% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 230.08M | -40.48% |
Total assets | 398.82M | -19.46% |
Total liabilities | 249.91M | -2.89% |
Total equity | 148.92M | — |
Shares outstanding | 21.19M | — |
Price to book | 1.61 | — |
Return on assets | -14.89% | — |
Return on capital | -15.68% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -22.66M | 42.00% |
Cash from operations | -14.78M | 54.01% |
Cash from investing | -6.34M | 95.65% |
Cash from financing | -6.65M | -103.33% |
Net change in cash | -27.77M | -226.22% |
Free cash flow | -16.75M | 18.84% |
About
Founded
1995
Headquarters
Website
Employees
145